Monday, April 8, 2019

Allergan's failed depression drug shows promise in opioid withdrawal - FierceBiotech

Allergan's failed depression drug shows promise in opioid withdrawal  FierceBiotech

Allergan's rapastinel, the centerpiece of its $560 million acquisition of Naurex, recently failed in pivotal trials in depression. But scientists at Duke University and ...

(CLICK HERE TO READ AND SEE MORE

0 comments:

Post a Comment